As of December 2024, Cellectar Biosciences has a market cap of $2.95M. This makes Cellectar Biosciences the world's 33369th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $43.19M | 26.90% |
2023 | $34.04M | 61.99% |
2022 | $21.01M | -74.09% |
2021 | $81.10M | -68.27% |
2020 | $255.60M | -7.56% |
2019 | $276.49M | 45.16% |
2018 | $190.47M | -88.69% |
2017 | $1.68B | 12.30% |
2016 | $1.50B | -83.51% |
2015 | $9.09B | -76.05% |
2014 | $37.97B | -58.24% |
2013 | $90.93B | -50.00% |
2012 | $181.87B | 68.18% |
2011 | $108.14B | -90.41% |
2010 | $1.13T | -98.81% |
2009 | $94.76T | 436.17% |
2008 | $17.67T | -20.34% |
2007 | $22.19T | -32.18% |
2006 | $32.71T | -56.50% |
2005 | $75.20T | - |